Low chronic pacing thresholds of steroid-eluting active-fixation ventricular pacemaker leads: a useful alternative to passive-fixation leads

Pacing Clin Electrophysiol. 2000 Nov;23(11 Pt 2):1798-800. doi: 10.1111/j.1540-8159.2000.tb07022.x.

Abstract

Active-fixation pacemaker leads enable pacing at various sites, have a low dislodgment rate, and are easier to extract than passive-fixation leads, though are usually not routinely implanted in the ventricle because of their higher pacing threshold. The long-term pacing threshold associated with an active-fixation steroid-eluting lead was prospectively measured in 18 women and 20 men. At a mean follow-up of 14 months (range 3-25 months), pacing threshold increased from 0.71 +/- 0.29 V to 0.96 +/- 0.28 V (P = 0.01) between implant and the first month of follow-up, then remained stable over time, consistently allowing the long-term programming of the ventricular output at 2.5 V, while lead impedance remained stable (from 647 +/- 161 omega at implant to 666 +/- 122 omega at last follow-up). If the long-term performance of this type of lead is confirmed, the routine implantation of ventricular steroid-eluting active-fixation leads should be considered since lead extraction has become a major concern.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Arrhythmias, Cardiac / physiopathology
  • Arrhythmias, Cardiac / therapy*
  • Cardiac Pacing, Artificial / methods*
  • Chronic Disease
  • Dexamethasone / administration & dosage
  • Dexamethasone / analogs & derivatives*
  • Drug Implants
  • Electrodes, Implanted / standards*
  • Female
  • Follow-Up Studies
  • Heart Ventricles / physiopathology
  • Heart Ventricles / surgery*
  • Humans
  • Male
  • Middle Aged
  • Pacemaker, Artificial*
  • Prospective Studies
  • Sensory Thresholds
  • Treatment Outcome

Substances

  • Drug Implants
  • Dexamethasone
  • dexamethasone acetate